AstraZeneca/Daiichi Sankyo Line Up More Enhertu Indications

Promising Phase II Data In Multiple Tumor Types

 
• By Kevin Grogan
  
Dart
Enhertu on target for more indications • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Anticancer

More from Therapeutic Category